Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Smith & Nephew Snats ( (SNN) ) has issued an announcement.
Smith & Nephew plc, a company operating in the medical technology industry, announced a transaction involving the purchase of American Depositary Shares (ADS) by KAGAMA Family Investments, LP, which is closely associated with Garheng Kong, an Independent Non-Executive Director. The transaction, which took place on November 6, 2025, at the New York Stock Exchange, involved the purchase of 3,000 ADS at a price of $33.9773 each. This notification is made in compliance with the UK Market Abuse Regulation, reflecting the company’s commitment to transparency in its financial dealings.
The most recent analyst rating on (SNN) stock is a Hold with a $36.00 price target. To see the full list of analyst forecasts on Smith & Nephew Snats stock, see the SNN Stock Forecast page.
Spark’s Take on SNN Stock
According to Spark, TipRanks’ AI Analyst, SNN is a Neutral.
Smith & Nephew Snats’ strong financial performance and positive earnings call are the main drivers of its stock score. However, bearish technical indicators and a high P/E ratio temper the overall outlook. The company’s strategic initiatives, such as the share buyback, reflect confidence in its financial health, but challenges in emerging markets and tariff impacts pose risks.
To see Spark’s full report on SNN stock, click here.
More about Smith & Nephew Snats
Average Trading Volume: 667,925
Technical Sentiment Signal: Buy
Current Market Cap: $15.51B
For detailed information about SNN stock, go to TipRanks’ Stock Analysis page.